Anti-CIITA antibody (ab7541)
- Datasheet
- References (2)
- Protocols
Overview
-
Product nameAnti-CIITA antibody
See all CIITA primary antibodies -
DescriptionRabbit polyclonal to CIITA
-
Host speciesRabbit
-
Tested applicationsSuitable for: Conjugation, Dot blot, ELISA, IP, WB, Flow Cytmore details
-
Immunogen
Synthetic peptide:
CGEIKDNKELPQYLALTTR
conjugated to KLH - which corresponds to a region near the C-terminal end (amino acids 726-742) of the protein encoded by the human CIITA gene.CIITA.
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
-
Storage bufferpH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 0.42% Potassium phosphate, 0.87% Sodium chloride -
Concentration information loading... -
PurityIgG fraction
-
Purification notesThis product was prepared from monospecific antiserum by delipidation and defibrination.
-
ClonalityPolyclonal
-
IsotypeIgG
-
Research areas
Associated products
-
Compatible Secondaries
Applications
Our Abpromise guarantee covers the use of ab7541 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| Conjugation | Use at an assay dependent concentration. | |
| Dot blot | Use at an assay dependent concentration. | |
| ELISA | Use at an assay dependent concentration. | |
| IP | Use at an assay dependent concentration. | |
| WB | Use at an assay dependent concentration. Predicted molecular weight: 123 kDa. | |
| Flow Cyt | Use at an assay dependent concentration. PubMed: 17586661 ab171870 - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.
|
Target
-
FunctionEssential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter. Also mediates enhanced MHC class I transcription; the promoter element requirements for CIITA-mediated transcription are distinct from those of constitutive MHC class I transcription, and CIITA can functionally replace TAF1 at these genes. Exhibits intrinsic GTP-stimulated acetyltransferase activity. Exhibits serine/threonine protein kinase activity: can phosphorylate the TFIID component TAF7, the RAP74 subunit of the general transcription factor TFIIF, histone H2B at 'Ser-37' and other histones (in vitro).
-
Involvement in diseaseBare lymphocyte syndrome 2
-
Sequence similaritiesContains 4 LRR (leucine-rich) repeats.
Contains 1 NACHT domain. -
DomainThe acetyltransferase domain is necessary for activation of both class I and class II transcription.
The GTP-binding motif doesn't confer GTPase activity but promotes nuclear localization. -
Post-translational
modificationsAutophosphorylated, affecting interaction with TAF7. -
Cellular localizationNucleus. Nucleus, PML body. Recruited to PML body by PML.
- Information by UniProt
-
Alternative names
- C2TA antibody
- C2TA_HUMAN antibody
- CIITA antibody
see all
Datasheets and documents
References
This product has been referenced in:
- Christova R et al. P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma. J Cell Sci 120:3262-70 (2007). WB ; Human . Read more (PubMed: 17726060) »
- Herrmann TL et al. MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II. J Leukoc Biol 82:686-99 (2007). Flow Cyt . Read more (PubMed: 17586661) »
